MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMARepresents ...

One dose of modified vaccinia Ankara-Bavarian Nordic vaccine is moderately effective against mpox infection in at-risk communities.

Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

Lessons learned from the Covid pandemic have left the world in a much better position to tackle the current mpox epidemic ...

MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA Represents the second EMA approval of an MVA-BN-based vaccine for a younger ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

The vaccine alliance Gavi has announced a deal with the Danish drugmaker Bavarian Nordic for 500,000 doses of its MVA-BN mpox ...

Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...

Gavi, the Vaccine Alliance, will purchase 500,000 doses of MVA-BN, the Bavarian Nordic Mpox vaccine, as part of an ...

It added: Bavarian Nordic A/S (OMX: BAVA) and Gavi, the Vaccine Alliance today announced an advance purchase agreement (APA) ...